lupus Flashcards

1
Q

Lupus
what is lupus

A

● Inflammatory autoimmune disorder
○ 85% female (7-15:1 female:male)
■ sex hormones play a role – majority diagnosed between menarche and menopause
○ prevalence: 0.02-0.15% overall
■ ethnicity: 1:1000 in white females, 1:250 in black females
○ familial occurrence (HLA haplotypes, other)
■ serologic abnormalities (ANA+) without SLE manifestations
■ other rheumatic conditions
○ environmental:
■ smoking (trigger)
■ UV light (exacerbates)

estrogen is protective for gout, just like in cardiovascular disease. And as estrogen levels wane in menopause, then we see an increase in certain diseases in women. And so again, sex hormones play a role here can actually be a trigger for lupus. And the majority of people are diagnosed between menarche and menopause. Similarly for transgender women who are taking estrogen, they can, if they’re otherwise genetically predisposed, actually sort of spur the onset of a lupus diagnosis.

it does affect more black women compared to white women. And Latina. And women are also a little bit more affected as well. There is that familial occurrence. So again, we’ve got a genetic predisposition with these changes in the HLA haplotypes. And folks who are in the family but aren’t exhibiting any symptoms of lupus might also have a positive ANA, which is one of the autoantibodies and may never go on to actually get lupus. Or there’s such a familial sort of link between all of the rheumatic diseases. Somebody who’s got a positive and a might actually go on to have rheumatoid arthritis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Lupus: Pathophysiology

A

● Production of antibodies to nuclear, cytoplasmic, cell surface, and
soluble antigens, leading to systemic inflammation
● Clinical presentation is variable:
○ Manifestations
■ simply skin & joint manifestations – Cutaneous Lupus Erythematosus
■ organ & life-threatening disease – Systemic Lupus Erythematosus
○ Pattern
■ usually relapsing-remitting
■ can be continuous

the low-grade fever, anorexia, weight-loss, malaise, or are really predominant in lupus.

damage to the DNA from UV light or any other type of environmental trigger that is causing these auto antibodies to any number of different cell types and various facets in the body. Because there can be a number of different types of auto antibodies and different systems can actually be affected. So some folks with a diagnosis of lupus will have more just skin manifestations with some joints being affected. And we would call that cutaneous lupus erythematosus. That can actually progress to be more systemic.

oregon life threatening diseases, tons of inflammation. So needing careful attention and quick treatment, the pattern is is usually relapsing and remitting. So not so much like rheumatoid arthritis, which can vary over time, but really quite quiescent periods of time. And then the relapses might be triggered by some type of environmental or other cause. But the pattern can also be continuous and progressive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Lupus: Clinical Findings
constitutional
skin

A

● Constitutional: fever, anorexia, malaise, weight loss
● Skin (90%)
○ malar (‘butterfly’) rash (<50%) or discoid rash (most common)
○ photosensitivity (rash following sun exposure)
○ painless mucous membrane lesions (during exacerbation)
○ alopecia – patchy or diffuse

But you can see this outline across the bridge of the nose and into the cheeks. What’s really interesting is the nasal labial folds are spared. So that’s why it kinda looks more like a butterfly.
discoid rash. Which is red and raised and scaly and might be confused for some other type of subarea or some other type of keratitis.
, quick treatment and resolution of that rash can help to prevent some of that scarring (discoid).

it’s not like the little maculopapular itchy rash that happens with sun exposure within minutes to hours. This is an auto-immune reaction. So it takes a week to actually get started and going. And it’s almost like just the worst sunburn you could imagine across the whole body. And then it takes weeks to months to resolve with good treatment. So avoiding UVA and UVB light is incredibly important

it’s not like the little maculopapular itchy rash that happens with sun exposure within minutes to hours. This is an auto-immune reaction. So it takes a week to actually get started and going. And it’s almost like just the worst sunburn you could imagine across the whole body. And then it takes weeks to months to resolve with good treatment. So avoiding UVA and UVB light is incredibly important

painless mucus membranes. So I mentioned that allegiance MJ had all these lesions in her mouth and nose. She had no idea. So they’re there. They can flare up during exacerbations. discoid scars that are on the scalp, they will lose the ability to grow hair in that, in that area permanently.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lupus: Clinical Findings
● Joint
muscles

A

● Joint
○ symmetrical, polyarticular, with or without active synovitis (>90%)
■ less severe, less swelling, shorter morning stiffness than RA
■ reducible swan-neck deformities (erosive changes rare)
● Muscles
○ myalgia (50-80%) or myositis (5-10%), tendonitis (10%)

Muscle soreness also really common, less so inflammation of the muscle or the tendons.
different than rheumatoid arthritis, tend to be less severe, less red-hot, squishy, but still the same kind of pattern in terms of which joints are affected.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lupus: Other Clinical Findings

A

Ophthalmologic keratoconjunctivitis sicca, photophobia, blurred vision
Lung common: pleural effusion (50%), bronchopneumonia
rare: pneumonitis, restrictive lung disease, alveolar hemorrhage
Cardiovascular pericarditis, Raynaud phenomenon (20-30%), myocarditis (HF),
arrhythmia
Vasculitis medium sized vessels (aneurysm, narrowed)
Neurologic More Common: headache, mood changes, cognitive impairment,
seizures, stroke
Less Common: peripheral or cranial neuropathies
Renal glomerulonephritis
interstitial nephritis

high prevalence of Raynaud’s in people who have systemic lupus and then renal disease, both glomerulonephritis and interstitial nephritis. So vote 50% of folks with systemic lupus will have renal involvement and about 10% of them will go on to end-stage renal disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lupus: Lab Findings
what autoantibodies are found

A

● Characterized by production of various autoantibodies:
○ ANA (antinuclear antibody): 95% sensitive (not as specific)
○ anti-dsDNA: 95% specific, 60% sensitive
■ levels also correlate with disease activity
○ Sm (Smith): 99% specific (30% sensitive)
○ antiphospholipid (APL):
■ lupus anticoagulant (7%)
■ anti-cardiolipin (25%)
● Hypocomplementemia: during active disease (60%)
● Other:
○ hematologic: anemia, leukopenia, thrombocytopenia
○ hematuria, proteinuria (renal disease)
○ mildly elevated ESR, CRP ( CRP and ESR don’t tend to be greatly elevated like they are in rheumatoid arthritis or in gout.)

The anti double-stranded DNA is incredibly specific, 95% specific. So we’re almost guaranteeing if that’s positive, that this is lupus. And the Smith antibody even more specific for lupus.

patients who have antiphospholipid antibodies will be more likely to have VTE are more prone to pregnancy loss. We need to think about anticoagulation depending what, what clots they present with. In

With lupus, the anti double-stranded DNA and complement levels actually vary with the disease. So in order to confirm that someone is in a flare, we can see whether they’re anti double-stranded DNA levels are increased and their complement levels are decreased. So the complement gets released and used up almost so that the normal level dips during active disease.

Lupus can also affect all three cell lines. So when it’s active, patients can have anemia, decreased hemoglobin, leukopenia, thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lupus: Rule Out Drug-Induced Lupus

A

Tnf inhibitors are interesting because they can actually spur real lupus in predisposed people, but they can also cause a drug-induced reversible lupus. So figuring that out obviously would be important, but TNF inhibitors are contraindicated for patients who have a diagnosis of lupus.

● Numerous drugs associated with lupus
○ Hydralazine, isoniazid, procainamide, chlorpromazine, minocycline
○ TNF inhibitors (RA > IBD)
○ PPIs
● Features distinguishing drug-induced from SLE:
○ Sex ratio equal, tends to affect older people
○ Renal, CNS features are absent
○ ANA positive – but:
■ No hypocomplementemia & dsDNA Ab negative
○ Clinical features & lab abnormalities disappear when drug withdrawn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lupus: Complications

A

● Accelerated atherosclerosis (independent RF)
○ Recommend assessment of CV RF at diagnosis and periodically
● End-stage renal disease
● Infections
● Osteoporosis & Avascular Necrosis
○ Recommend assessment of OP risk and fractures every 1-3y, education on
osteonecrosis
● Malignancy
○ lymphoma, lung, cervical (annual screening) So anyone who has a cervix should have annual screening right from diagnosis no matter how old they are.

young people who have a diagnosis of lupus have a relative risk of cardiovascular complications that is just extraordinary but still quite rare

We want to think about treating any modifiable cardiovascular risk factors. End stage renal disease. Obviously we want to try and avoid. So for anyone who does have renal manifestations that monitoring every three months of, of GFR urinalysis is incredibly important.

Osteoporosis and avascular necrosis. So this is probably more treatment-related than disease related at this point. We use a lot of steroids in patients who have lupus. That regular use or higher dose over longer periods of time obviously increases the risk of osteoporosis.

avascular necrosis happens when these tiny little microthrombi cause micro fractures in the bone that over time add up. And that dead bone essentially creates a collapse in the joint. So this is luckily quite painful. And so you can tell patients that this is very rare, but if you have a new severe joint pain tends to be the hips, sometimes the shoulders but the hips or for some reason particularly predisposed to this. Then we want, we want to get people off of those steroids as quickly as possible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lupus: Treatment
goals

A

Ø Disease manifestations vary and activity waxes & wanes
○ Requires individualization of therapy!
● Goals:
○ Manage symptoms and prevent damage & complications
○ Control inflammation and autoimmune activation
○ Improve long term survival and quality of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lupus: Treatment – Most Patients
nonpharm
pharm?

A

● Non-pharmacological
○ avoid prolonged sun exposure (SPF ≥30, physical)
○ tobacco cessation
○ calcium, vitamin D
● NSAIDs PRN
○ minor joint & MSK symptoms
○ pleuritis or pericarditis
● Antimalarials (hydroxychloroquine 200-400mg/d)
○ lupus rash and joint symptoms (constitutional symptoms)
○ core drug therapy for patients with lupus (max 5mg/kg/d)

s. So effective for the rash types of symptoms, joint symptoms really is the core drug therapy. So it will be more unusual to see a patient not on hydroxychloroquine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lupus: Treatment – Some Patients

A

● Steroids
○ topical (hydrocortisone) for cutaneous manifestations
■ alternative: calcineurin inhibitors (tacrolimus, pimecrolimus)
○ oral for systemic complications

● Immunomodulators: systemic lupus erythematosus
○ methotrexate, azathioprine
○ belimumab (Benlysta) - BLyS inhibitor
○ anifrolumab (Saphnelo) – Type I Interferon inhibitor
○ deucravacitinib (Sotyktu) – TYK1 inhibitor (not yet marketed)

● Immunosuppressants: renal disease
○ cyclophosphamide, mycophenolate mofetil, cyclosporine
○ belimumab (new: lupus nephritis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lupus: Additional Treatments

A

● Anti-phospholipid Syndrome: anticoagulation
● Cardiovascular Disease
○ manage modifiable risk factors (DM, HTN, lipids, tobacco)
● Vaccination: influenza, pneumococcal, HPV
● PJP Prophylaxis
○ prednisone >20mg/d for 2 weeks
○ cyclophosphamide + additional RF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Case: Ms. Jones
● MJ is a 26yo nurse (she/her, sex assigned at birth female) (65kg) who
was recently discharged from hospital following her presentation to
emergency for chest pain and shortness of breath
○ Clinical Findings:
■ fatigue, malaise, 8lb weight loss
■ malar rash, photosensitivity, Canker sores in mouth & nose
■ arthritis of PIPs, wrists
■ Class II glomerulonephritis
○ New Medications:
■ hydroxychloroquine 400mg po daily
■ prednisone 15mg po daily
■ ramipril 5mg po daily
Are her prescribed medications reasonable?

A

Hydrxychlorquine: a little bit higher than the max 55 per kilos might be an intervention at this point that we would make to try and decrease that. So most commonly people would be on the 200 alternating with 401 tablet, alternating with two. To get within that range.

specifically the pericarditis inflammation can be quite painful. And so prednisone is incredibly effective. And as pharmacists, we would be thinking about how long is that prednisone being split, going to stay on. Do we have a plan to taper? So if you’re getting a prescription that just says 15 mg daily, you would want to figure out what that what that plan is. And I would say that MJ would have prednisone over weeks but not months.

Ramipril - renal protection, showing some risk for progression with with that glomerulonephritis. We want to do our best to protect the kidney function. We would want to see check in with her that she’s got lab work every three months to follow that renal function a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Adherence

A

I had to stop taking [my medicine]
because of insurance problems and
that’s when I got kidney failure…
That CellCept pill is not little at all! I can pop
my prednisones all day because they’re ittybitty. But just having to take 3 of those twice-aday, on top of all these other pills, it makes
you not want to do it.
I didn’t see the activity of my lupus. So, I’m
thinking, “Why do I need CellCept? I’m fine, I’m
great, I don’t have lupus, what are y’all talking
about?” It’s probably a mistake.
‘Are me and my son and my
family gonna eat or am I gonna
get this medicine?’
You have friends that do the Google research, or a
friend of a friend who has lupus, and they’re not
taking any medications. Numerous people try to tell
me, “Go gluten free, go vegan, you’ll be fine, you
don’t have to take all these medicines polluting your
body. That’s what’s making you sick.”
I’m always running, so I’m never at
home, so I’ll either run out, forget
to take my medicine, or I come
home and pass out.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lupus: Role of the Pharmacist

A

● Ensure symptoms related to SLE are not drug induced
● Support adherence
● Preventative measures important
○ Monitor and treat CV risk factors
○ Monitor prednisone dose and BMD if necessary
○ Monitor renal function regularly
○ Ensure patients are appropriately vaccinated
○ Counsel regarding sun block
● Be aware of:
○ potential skin rash or flare with use of sulfonamide drugs
○ potential flare (HRT) and clots (HRT, OCP) with estrogen therapy

And so if folks are particularly sensitive, they may not tolerate those sulfonamides drugs. So again, thinking about that for someone who might need PJP prophylaxis and using dapsone instead of trimethoprim sulfamethoxazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Seronegative Spondyloarthropathies

A

● Inflammatory arthritis of the spine and sacroiliac joints, associated with:
○ Enthesopathy (enthesitis)
■ inflammation where ligaments, tendons, & joint capsule insert into bone
■ dactylitis (‘sausage digit’) = inflammation of an entire digit (toe>finger)
○ And sometimes:
■ Asymmetric oligoarthritis of large peripheral joints
■ Uveitis = swelling & irritation of the uvea: intense pain, redness, photophobia
● Absence of autoantibodies in the serum
● HLA-B27 gene (sensitive, but not specific)
● male predominance, onset before 40y (prevalence ~1%)

It is an inflammatory arthritis that predominantly affects the spine and the tendons and ligaments that attach to the bones in the spine, but also in the joints, sometimes in smaller appendages like fingers and toes that inflammation in those tendons and ligaments can be so substantial that the entire finger or the entire TO actually swells up
shoulders and hips, maybe knees and elbows would be more impacted than any other peripheral joint, but less common. And so it’s more really it’s the spinal side of things, particularly with ankylosing spondylitis.

17
Q

Ankylosing Spondylitis (AS)

A

● Chronic inflammatory disease of the axial skeleton
○ gradual onset of pain & progressive stiffening of the spine (lumbar spine, sacroiliac joints)
● Pathogenesis is really unknown
○ changes are symmetrical and bilateral
○ familial pattern
● SI Joint
○ sacroiliitis à bony ankylosis
■ syndesmophytes form bony bridges - cartilage is literally replaced by bone!
● Spine
○ outer annular fibres (outer layer covering intervertebral discs)
may also become replaced by bone (“bamboo spine”)

more specifically, is this impacting of the axial skeleton. So if you remember from rheumatoid arthritis, the axial skeleton was the only sort of joint system that isn’t impacted.

So an actual hardening bone formation in the spinal processes. So in the sacroiliac joint as well as throughout the whole spine. So you can see in this patient from long ago over time a normal lumbar lordosis with that curve in the back that it gets flattened initially with a curvature in that thoracic spine. Eventually the hips are flexed, the neck is forward. And in this stage, which again is longstanding, uncontrolled ankylosing spondylitis. That entire spine is fused.

18
Q

AS: Clinical Findings

A

● Back Pain & Stiffness
○ pain – intermittent, may radiate to buttocks (alternates side to side)
○ stiffness (≥30min) – worse in morning (+ with rest)
○ improves with activity (not with rest)
○ progression leads to limited mobility, flattening of normal lumbar
curve, exaggerated thoracic curvature, and cervical kyphosis
■ advanced disease: spinal fusion – no motion in any direction
● Peripheral Joints (hips, knees, shoulders)
○ transient inflammation more common than permanent damage
● Enthesopathy
○ achilles tendon, plantar fasciitis, dactylitis
● Other
○ uveitis, IBD
○ rarely constitutional symptoms

substantial low back pain that radiates into the buttocks and it can move from one side to the other. One of the best ways to distinguish mechanical back pain from ankylosing spondylitis is the stiffness and the movement
stiffness, inflammatory conditions lasting longer than 30 min. Non-inflammatory joint disease like osteoarthritis, less than 30 min,

worse in the morning with rest, better with activity inflammatory related.

19
Q

AS: Treatment

nonpharm
and 1st line

A

● Non-Drug
○ PT for postural exercises & ROM
○ tobacco cessation
○ surgery: total hip arthroplasty (5%)
● NSAIDs (1st line)
○ may slow radiographic progression
■ Controversy: continuous vs. on-demand therapy
○ enables physical activity & exercises
● IA Steroid
○ symptomatic relief of individual joint(s), entheses
treat to target

you need to fail to therapeutic dose trials of nsaids for 4weeks before getting coverage for TNF inhibitor. So nsaids are actually not just trimming the trees in this case, they’re actually impacting the disease pathophysiology. They long term in therapeutic doses actually decreased bone formation.

thinking about all of the things that we might need to do to support their GI health or cardiovascular risk, et cetera. If it’s, if it’s not particularly helpful or if their disease isn’t a low period than on-demand therapy is, is better and appropriate for folks

20
Q

AS: Treatment
dmards

A

● Sulfasalazine 1000mg BID
○ may be helpful, but only for peripheral arthritis
○ use of MTX may be considered (if TNFi not available)

● TNF Inhibitors
○ Traditionally: for NSAID-resistant axial disease, NSAID/csDMARD resistant
peripheral disease; refractory enthesitis or dactylitis
■ Moving towards being 1st line therapy
○ improve pain, stiffness, function, and quality of life
○ Uveitis, IBD: use MAb (not ETN)
○ generally used without MTX
Tnf inhibitors are becoming the mainstay. So lots of evidence to support their efficacy and where we used to have to reserve them. Folks are more readily able to access TNF inhibitors. J

  • because AS is seronegative, we don’t have those auto antibodies. We don’t need to use methotrexate in combination to prevent those auto antibodies from clearing the drug from the system.
21
Q

AS: Treatment

A

● Other Advanced Therapies
○ IL-17a mAb (2nd line after TNFi)
■ secukinumab (Cosentyx): LD, 150mg subcut monthly
■ ixekizumab (Taltz): LD, 80mg subcut q4wks (not covered ABC)
○ JAKi (3rd line after IL-17i)
■ tofacitinib (Xeljanz): 5mg po BID (no indication (yet?))

● Not Recommended (lack efficacy)
○ rituximab, abatacept, ustekinumab, IL-6i, apremilast

22
Q

Psoriatic Arthritis (PsA)

A

● Chronic inflammatory arthritis associated with skin and nail psoriasis,
affecting the SI joints, axial skeleton, and/or peripheral joints
● Patterns can include:
1. symmetric polyarticular (like RA)
2. asymmetric oligoarticular (can be (rapidly) destructive)
3. DIP involvement
■ may be monoarticular or asymmetric polyarticular
■ associated with pitting of nails & onycholysis
4. severe deforming arthritis with marked osteolysis
5. spondylitic form (like AS)
■ unilateral sacroiliitis, axial involvement often asymptomatic (50% HLA-B27+)
● Dactylitis & enthesitis are also common

Sometimes the arthritis happens first and sometimes patient has an arthritis and doesn’t have any psoriasis patches themselves, but they have a family member that has psoriasis. So if they’ve got that very classic rheumatoid arthritis picture. But no skin disease and no rheumatoid factor or APA. Then we’ll call them a psoriatic arthritis is the most likely diagnosis.

Nail Pitting, Onycholysis, DIP Deformity, Dactylitis
Psoriatic arthritis more commonly affects the distal interphalangeal joint and the PIPs, but not the MCPs. So you will see some deformities that it looked very similar to osteoarthritis type deformities in those distal joints.

23
Q

Associated Features
of psor arth

A

● Constitutional symptoms:
○ fatigue, sleep disturbance
● Comorbidities:
○ obesity
○ CV risk factors: HTN, DM, dyslipidemia
○ depression, anxiety

24
Q

PsA: Treatment

A

● Adjunct / Bridging Therapies
○ NSAIDs, steroids (PO/IM or IA)
● Methotrexate (target 25mg weekly)
○ can improve both cutaneous & joint manifestations
○ other DMARDs have also been used, often in combination
■ LEF, SSZ, HCQ
■ PDE4 inhibitor: apremilast (Otezla) 30mg BID (titrated up) (not covered ABC) x
● TNF Inhibitors – any of the 5 available (2nd line)
○ significant & early efficacy in ¯cutaneous & arthritic symptoms, as well as axial
disease and enthesitis/dactylitis

similar to RA
leflunomide is less effective in psoriatic than it is in rheumatoid.

25
Q

How Effective Are They?
PA tx

A

ACR 20/50/70
Response
TNFi 65 / 45 / 30%
IL-17i* SEC* IXE
55 / 35 / 20%
70 / 50 / 30%

JAKi: TOF 50 / 30 / 17%
IL-12/23i: UST 45 / 25 /12%
CTLA4i: ABA 40 / 20 / 10%
PDE4: APR 35 / 20 / 10%

similar to RA
Maybe the TNF inhibitors as a first option are a little bit more effective even with that ACR response. But again, law of diminishing returns AND, and, OR even with initial therapy, you can see the JAK inhibitors just aren’t as good as they as they are with rheumatoid arthritis, but certainly an option.

26
Q

SpA: Role of the Pharmacist

A

● Recognize that ‘back’ & ‘joint’ pain can be due to a variety of diseases;
appropriate diagnosis is key
○ Monitor and manage pain & inflammation to prevent joint damage & enable physical
activity
● Ensure use of NSAIDs appropriate
○ Recognize risk of regular use (CV, GI, renal)
■ use PRN if possible
○ AS: adequate trial before moving on to other therapies
● Monitor efficacy & safety of DMARDs, steroids
● Manage comorbidities
○ cardiovascular risk factors
○ depression, anxiety
○ infections (vaccination)

make sure that that continues to be safe and that they are having trial periods where they’re stopping them and seeing whether that back pain has resolved

27
Q

Juvenile Idiopathic Arthritis (JIA)

A

● group of disorders that are a major cause of “chronic arthritis” in
children
○ cause short- and long-term disability
● Diagnosis made after ≥6 weeks of symptoms, classified into subsets
based on:
○ age at onset
○ number of joints involved initially
○ rheumatoid factor status
○ extra-articular symptoms
Ø Most common subtype is very similar to RA

28
Q

JIA: Treatment

A

Early detection and treatment is important to prevent complications
(eyes, joint erosions or deformity, stunted growth)
○ 50% of children with JIA will have continued active disease into adulthood
○ Goal: remission of joint inflammation; normal function; prevent
complications
● NSAIDs & Glucocorticoids (IA or PO)
○ first line in oligoarticular, seronegative polyarticular
● DMARDs
○ required for seropositive polyarticular, systemic JIA
○ csDMARDs: MTX > LEF, CsA; SSZ, HCQ
○ bDMARDs:
■ TNFi: etanercept, adalimumab, golimumab, infliximab (not certolizumab)
■ Other: tocilizumab, abatacept, anakinra, rituximab (not covered ABC)

29
Q

read non-articular rheumatism
and hypermobility joint disorder

A

ok